Thanks a lot, Mr. Chair.
We get to the basis here: expensive drugs and access to certain drugs.
Maybe to Ms. Fralick, how do we make sure that drugs are available and bring down the prices?
Those are the two things that need to happen here. Drug pricing needs to go down, and Canadians need to have access to those drugs. Where's that middle in terms of where PMPRB is and where pharmaceutical companies are?